Table 3. Outcomes and Complications of Coronary Revascularization with PVAD (Impella®) Support Following Acute Myocardial Infarction Complicated by Cardiogenic Shock With vs. Without Atrial Fibrillation (After Propensity-score Matching).

P-values <0.05 (bold) indicates clinical significance, AF= Atrial Fibrillation, pVAD=Percutaneous Ventricular Assist Device, AF=Atrial Fibrillation, AKI=Acute Kidney Injury, SNF=Skilled Nursing Facility, ICF=Intermediate Care Facility

Note: Cell counts <11 are not reported as per the privacy guidelines by HCUP.

Complications	1:1 Propensity-Matched Cohorts	P
All-cause in-hospital mortality	154 (36.7%)	170 (40.5%)	0.245
Hemorrhage or hematoma complicating a procedure	30 (7.1%)	20 (4.8%)	0.147
In-hospital cardiac arrest	245 (32.0%)	181 (19.2%)	<0.001
Perioperative stroke	<11*	40 (9.5%)	<0.001
Postoperative respiratory complications	20 (4.8%)	40 (9.5%)	0.007
Postoperative AKI requiring dialysis	24 (5.8%)	20 (4.7%)	0.536
Postoperative infection	65 (15.5%)	75 (17.9%)	0.347
Septic shock	25 (6.0%)	35 (8.4%)	0.177
Disposition			<0.001
Routine	133 (30.2%)	75 (13.1%)
Transfer to short term hospital	54 (8.3%)	45 (4.7%)
Other transfers including SNF, ICF & others	164 (17.8%)	173 (27.3%)
Home health care	44 (7.1%)	91 (14.3%)
Mean Length of stay Mean (±SD)	9.1 (± 6.8) days	11.9 (± 10.1) days	<0.001
Mean hospital charges	$277,982	$308,478	0.008